139 related articles for article (PubMed ID: 18175346)
1. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.
Unger MM; Möller JC; Stiasny-Kolster K; Mankel K; Berg D; Walter U; Hoeffken H; Mayer G; Oertel WH
Mov Disord; 2008 Mar; 23(4):596-9. PubMed ID: 18175346
[TBL] [Abstract][Full Text] [Related]
2. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
[TBL] [Abstract][Full Text] [Related]
3. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
[TBL] [Abstract][Full Text] [Related]
5. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with
Bae YJ; Kim JM; Kim KJ; Kim E; Park HS; Kang SY; Yoon IY; Lee JY; Jeon B; Kim SE
Radiology; 2018 Apr; 287(1):285-293. PubMed ID: 29232183
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the substantia nigra echogenicity and
Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
[TBL] [Abstract][Full Text] [Related]
7. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
8. Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder.
Iwanami M; Miyamoto T; Miyamoto M; Hirata K; Takada E
Sleep Med; 2010 Apr; 11(4):361-5. PubMed ID: 20223708
[TBL] [Abstract][Full Text] [Related]
9. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
[TBL] [Abstract][Full Text] [Related]
10. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
[TBL] [Abstract][Full Text] [Related]
11. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
[TBL] [Abstract][Full Text] [Related]
12. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
[TBL] [Abstract][Full Text] [Related]
13. Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder.
Frosini D; Cosottini M; Donatelli G; Costagli M; Biagi L; Pacchetti C; Terzaghi M; Cortelli P; Arnaldi D; Bonanni E; Tosetti M; Bonuccelli U; Ceravolo R
Parkinsonism Relat Disord; 2017 Oct; 43():105-109. PubMed ID: 28781201
[TBL] [Abstract][Full Text] [Related]
14. Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy.
Li X; Xue S; Jia S; Zhou Z; Qiao Y; Hou C; Wei K; Zheng W; Rong P; Jiao J
Psychiatry Clin Neurosci; 2017 Apr; 71(4):238-246. PubMed ID: 27898200
[TBL] [Abstract][Full Text] [Related]
15. Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control.
Shin HY; Joo EY; Kim ST; Dhong HJ; Cho JW
Neurol Sci; 2013 Jun; 34(6):935-40. PubMed ID: 22843227
[TBL] [Abstract][Full Text] [Related]
16. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.
Sommer U; Hummel T; Cormann K; Mueller A; Frasnelli J; Kropp J; Reichmann H
Mov Disord; 2004 Oct; 19(10):1196-202. PubMed ID: 15390014
[TBL] [Abstract][Full Text] [Related]
17. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging of rapid eye movement sleep behavior disorder: transcranial ultrasound, single-photon emission computed tomography, and positron emission tomography scan data.
Miyamoto M; Miyamoto T
Sleep Med; 2013 Aug; 14(8):739-43. PubMed ID: 23648146
[TBL] [Abstract][Full Text] [Related]
19. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
[TBL] [Abstract][Full Text] [Related]
20. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
